Roland Sidabutar and Agung Budi Sutiono*

Department of Neurosurgery, Hasan Sadikin Hospital, Padjadjaran University, Bandung, Indonesia

*Corresponding Author: Agung Budi Sutiono, Department of Neurosurgery, Hasan Sadikin Hospital, Padjadjaran University, Bandung, Indonesia.

Received: December 04, 2021; Published: December 31, 2021

Abstract

Introduction: The management of giant sphenopetroclival meningioma (SPCM) remains a hurdle for clinicians in many countries. The development of the instrument and surgical technique have improved the clinical outcomes, especially in developed countries. However, the limitation of facilities as well as the cost remains a major in developing countries, like Indonesia. Our study aims to modify the neurosurgical services of SPCM by considering the limited cost and facilities in our institution.

Methods: We collected the data of SPCM within the year 2019 and evaluated the surgical approaches, outcomes, and cost-effectiveness based on the national insurance in Indonesia. Nine patients of SPCM have been noted and analyzed, in 4 patients the lesions were located on the right, while 5 patients had lesions on the left side. CT and/or MRI with contrast imaging were used to determine the tumor invasion and location. All patients were covered by national insurance with a limited budget.

Results: Through the year 2019, we operated on 9 patients with SPCM. The majority of the patients were female (6 out of 9). The average age was 46.78 years old. In our series, 1 patient had prolonged stay in the ICU (20 days) with total length of stay (LOS) of 32 days. This patient took extra cost during hospitalization, with a total of 6378 USD. The average LOS in ICU and ward were 2.25 days and 7.38 days respectively, excluding the outlier patient. The mean cost for the surgery of SPCM was 3683.78 USD.

Conclusion: The study concludes that patients with SPCM are still manageable based on Indonesian National insurance system although with many limitation.

Keywords: Giant Sphenopetroclival Meningioma (SPCM); Length of Stay (LOS); Tumor

References

1. Beer-Furlan A., et al. “Approach Selection and Surgical Planning in Posterior Cranial Fossa Meningiomas: How I Do It”. Journal of Neurological Surgery Part B: Skull Base 4 (2019): 380-391.
2. Abou-Al-Shaar H., et al. “Assessment of Costs in Open Microsurgery and Stereotactic Radiosurgery for Intracranial Meningiomas”. World Neurosurgery 119 (2018): e357-e365.
3. Boetto J., et al. “AB1 overexpression identifies hedgehog-activated anterior skull base meningiomas”. Neuropathology and Applied Neurobiology 6 (2021): 748-755.
4. Karsy M., et al. “EQ-5D Quality-of-Life Analysis and Cost-Effectiveness After Skull Base Meningioma Resection”. Neurosurgery3 (2019): E543-E552.
5. Troude L., et al. “Ipsilateral vs controlateral approach in tuberculum sellae meningiomas surgery: a retrospective comparative study”. Neurosurgery Review6 (2021): 3581-3591.
6. Raban D., et al. “Intracranial meningioma surveillance using volumetrics from T2-weighted MRI”. Journal of Neuroimaging (2021).
7. Haslund-Vinding J., et al. “Proposal of a new grading system for meningioma resection: the Copenhagen Protocol”. Acta Neurochirie (Wien) (2021).
8. Cannizzaro D., et al. “Intracranial Meningiomas in the Elderly: Clinical, Surgical and Economic Evaluation. A Multicentric Experience”. Cancers 12 (2020): 2685.

Citation

Citation: Roland Sidabutar and Agung Budi Sutiono. “Giant Sphenopetroclival Meningioma in Developing Countries: A Challenging Services with Limitation Facilities and Cost Analysis" Acta Scientific Neurology 5.1 (2022): 38-41.

Copyright

Copyright: © 2022 Roland Sidabutar and Agung Budi Sutiono. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.